Pasithea Therapeutics Corp (KTTA)
6.92
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
7.05
+0.13
(+1.88%)
After-Hours: 20:00
Pasithea Therapeutics Price to Book Value: 0.3083 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.3083 |
| May 02, 2024 | 0.3083 |
| May 01, 2024 | 0.3083 |
| April 30, 2024 | 0.3083 |
| April 29, 2024 | 0.3083 |
| April 26, 2024 | 0.3225 |
| April 25, 2024 | 0.3225 |
| April 24, 2024 | 0.3096 |
| April 23, 2024 | 0.3159 |
| April 22, 2024 | 0.3012 |
| April 19, 2024 | 0.3168 |
| April 18, 2024 | 0.3185 |
| April 17, 2024 | 0.3185 |
| April 16, 2024 | 0.323 |
| April 15, 2024 | 0.3185 |
| April 12, 2024 | 0.3323 |
| April 11, 2024 | 0.3408 |
| April 10, 2024 | 0.3653 |
| April 09, 2024 | 0.3674 |
| April 08, 2024 | 0.3764 |
| April 05, 2024 | 0.3787 |
| April 04, 2024 | 0.3898 |
| April 03, 2024 | 0.356 |
| April 02, 2024 | 0.3221 |
| April 01, 2024 | 0.323 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.323 |
| March 27, 2024 | 0.3185 |
| March 26, 2024 | 0.3252 |
| March 25, 2024 | 0.3177 |
| March 22, 2024 | 0.2984 |
| March 21, 2024 | 0.3193 |
| March 20, 2024 | 0.3028 |
| March 19, 2024 | 0.3037 |
| March 18, 2024 | 0.3168 |
| March 15, 2024 | 0.3105 |
| March 14, 2024 | 0.3206 |
| March 13, 2024 | 0.3239 |
| March 12, 2024 | 0.3217 |
| March 11, 2024 | 0.3339 |
| March 08, 2024 | 0.3245 |
| March 07, 2024 | 0.3206 |
| March 06, 2024 | 0.3225 |
| March 05, 2024 | 0.3179 |
| March 04, 2024 | 0.3415 |
| March 01, 2024 | 0.362 |
| February 29, 2024 | 0.3562 |
| February 28, 2024 | 0.3384 |
| February 27, 2024 | 0.325 |
| February 26, 2024 | 0.3295 |
| February 23, 2024 | 0.3304 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2056
Minimum
Dec 20 2023
98.89
Maximum
Sep 15 2021
2.022
Average
0.4408
Median
Jul 24 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
| NovaBay Pharmaceuticals Inc | 2.094 |
| Protalix BioTherapeutics Inc | 2.481 |
Price to Book Value Related Metrics
| Price | 6.92 |
| Earnings Yield | -188.0% |
| Market Cap | 7.213M |